OBJECTIVE:Exercise training has been shown to have anti-inflammatory effects in patients with type 2 diabetes. Changes in interleukin-6 (IL-6) serum concentrations in response to training could contribute to these beneficial effects. However, there are heterogeneous data on whether circulating IL-6 is altered by exercise training. We therefore hypothesize that genetic factors modify the individual changes in IL-6 levels after long-term training. RESEARCH DESIGN AND METHODS: The -174G/C variant in the IL-6 gene was genotyped in 60 subjects with impaired glucose tolerance. For a 12-month interventional study, patients were randomized into three groups: a control group (n=16) was compared with one group, which underwent a standardized training program (n=24) and another group, which was treated with 4 mg rosiglitazone once daily (n=20). At baseline, after 1, 6, and 12 months, we measured anthropometric parameters and serum concentration of IL-6 and, at baseline and after 12 months, we determined glucose tolerance and fitness level. RESULTS: Only in subjects carrying the SNP -174C allele did long-term exercise training result in significantly reduced IL-6 serum concentrations. Multivariate linear regression analysis identified the IL-6 genotype as a significant predictor of changes in IL-6 serum concentrations independent of age, gender and improvement in body mass index, hemoglobin (Hb)A(1c), and fitness level in response to training. CONCLUSIONS: Genetic variants in the IL-6 gene significantly modify changes in IL-6 serum concentrations in response to long-term exercise training programs. Our data suggest that genetic factors are important determinants for the individual response to anti-inflammatory effects of exercise training.
RCT Entities:
OBJECTIVE: Exercise training has been shown to have anti-inflammatory effects in patients with type 2 diabetes. Changes in interleukin-6 (IL-6) serum concentrations in response to training could contribute to these beneficial effects. However, there are heterogeneous data on whether circulating IL-6 is altered by exercise training. We therefore hypothesize that genetic factors modify the individual changes in IL-6 levels after long-term training. RESEARCH DESIGN AND METHODS: The -174G/C variant in the IL-6 gene was genotyped in 60 subjects with impaired glucose tolerance. For a 12-month interventional study, patients were randomized into three groups: a control group (n=16) was compared with one group, which underwent a standardized training program (n=24) and another group, which was treated with 4 mg rosiglitazone once daily (n=20). At baseline, after 1, 6, and 12 months, we measured anthropometric parameters and serum concentration of IL-6 and, at baseline and after 12 months, we determined glucose tolerance and fitness level. RESULTS: Only in subjects carrying the SNP -174C allele did long-term exercise training result in significantly reduced IL-6 serum concentrations. Multivariate linear regression analysis identified the IL-6 genotype as a significant predictor of changes in IL-6 serum concentrations independent of age, gender and improvement in body mass index, hemoglobin (Hb)A(1c), and fitness level in response to training. CONCLUSIONS: Genetic variants in the IL-6 gene significantly modify changes in IL-6 serum concentrations in response to long-term exercise training programs. Our data suggest that genetic factors are important determinants for the individual response to anti-inflammatory effects of exercise training.
Authors: Daniele Sirineu Pereira; Elvis Cristian Cueva Mateo; Bárbara Zille de Queiroz; Alexandra Miranda Assumpção; Aline Silva Miranda; Diogo Carvalho Felício; Natália Pessoa Rocha; Daniela Maria da Cruz dos Anjos; Danielle Aparecida Gomes Pereira; Antonio Lucio Teixeira; Leani Souza Máximo Pereira Journal: Age (Dordr) Date: 2013-02-21
Authors: Amina Nadeem; Sadaf Mumtaz; Abdul Khaliq Naveed; Muhammad Aslam; Arif Siddiqui; Ghulam Mustafa Lodhi; Tausif Ahmad Journal: World J Diabetes Date: 2015-05-15
Authors: E A Murphy; J M Davis; T L Barrilleaux; J L McClellan; J L Steiner; M D Carmichael; M M Pena; J R Hebert; J E Green Journal: Cytokine Date: 2011-05-19 Impact factor: 3.861
Authors: Sabina Cauci; Manuela Di Santolo; Kelli K Ryckman; Scott M Williams; Giuseppe Banfi Journal: BMC Med Genet Date: 2010-02-22 Impact factor: 2.103
Authors: Phoebe A Stapleton; Adam G Goodwill; Milinda E James; Robert W Brock; Jefferson C Frisbee Journal: J Inflamm (Lond) Date: 2010-11-18 Impact factor: 4.981
Authors: Ana I Faustino-Rocha; Adelina Gama; Paula A Oliveira; Antonieta Alvarado; Maria J Neuparth; Rita Ferreira; Mário Ginja Journal: Clin Exp Med Date: 2016-04-19 Impact factor: 3.984
Authors: Antti Huuskonen; Minna Tanskanen; Jani Lappalainen; Niku Oksala; Heikki Kyröläinen; Mustafa Atalay Journal: J Sports Sci Med Date: 2009-06-01 Impact factor: 2.988